Journals / Experimed / 2023 / Cilt: 13 Sayı: 1

Delta Secretase and BDNF Signalling in Alzheimer’s Disease

Journal
Experimed
Pages
1–7
Publication Date
2023-05-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we focus on the activity of δ-secretase, how it leads to tau hyperphosphorylation, and how it disrupts the axonal transport of BDNF in Alzheimer's disease

📌 3 Key Takeaways

🎯
Objective & Hypothesis:As one of the major contributors of the central nervous system, neurons require neurotrophic factors, which are synthesized from neighbouring cells, for several cellular processes, such as neuronal survival, growth, and differentiation.
📊
Key Findings & Data:The neurotrophin family comprises four growth factors: nerve growth factor (NGF), neurotrophin-3 (NT3), neurotrophin-4 (NT4), and brain-derived neurotrophic factor (BDNF).
💡
Conclusion & Impact:In this review, we focus on the activity of δ-secretase, how it leads to tau hyperphosphorylation, and how it disrupts the axonal transport of BDNF in Alzheimer's disease
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:BDNF · axonal transport · delta secretase

Abstract

As one of the major contributors of the central nervous system, neurons require neurotrophic factors, which are synthesized from neighbouring cells, for several cellular processes, such as neuronal survival, growth, and differentiation. Neurotrophic factors are categorized into the neurotrophin family, the neuropoietic cytokines, and the glial cell-derived neurotrophic factor. The neurotrophin family comprises four growth factors: nerve growth factor (NGF), neurotrophin-3 (NT3), neurotrophin-4 (NT4), and brain-derived neurotrophic factor (BDNF). One of the best-known neurotrophic factors is BDNF. Its importance is based on its central role in neuronal survival. Entry of the BDNF into the neurons occurs via TrkB receptors, and it is transported to the cell body along microtubules in axons. As it is known in the brains of Alzheimer's patients, the axonal transport of BDNF is destructed via the hyperphosphorylated tau. There are several causes for the hyperphosphorylation of tau. Among them, delta secretase (δ-secretase), a lysosomal cysteine protease, cleaves both amyloid precursor protein (APP) and tau. It is supposed to play an essential role in tau hyperphosphorylation, particularly in the aging brain. In this review, we focus on the activity of δ-secretase, how it leads to tau hyperphosphorylation, and how it disrupts the axonal transport of BDNF in Alzheimer's disease

🔖

Cite This Article

ÜNLÜ, B., ILDIZ, S., AK, D. G., DURSUN, E. (2023). Delta Secretase and BDNF Signalling in Alzheimer’s Disease. Experimed, Cilt: 13 Sayı: 1, 1–7. https://ajindex.com/articles/936348

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Association As. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 2016
  2. 12(4): 459-509. [CrossRef] google scholar 2. Kumar A, Sidhu J, Goyal A, Tsao JW, Doerr C. Alzheimer Disease (Nursing). StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC.
  3. google scholar 3. Ovsepian SV, O’Leary VB, Zaborszky L, Ntziachristos V, Dolly JO. Amyloid plaques of Alzheimer’s Disease as hotspots of glutamatergic activity. Neuroscientist 2019
  4. 25(4): 288-97. [CrossRef] google scholar 4. Kuznetsov IA, Kuznetsov AV. How the formation of amyloid plaques and neurofibrillary tangles may be related: a mathematical modelling study. Proc Math Phys Eng Sci 2018
  5. 474(2210): 20170777. [CrossRef] google scholar 5. Zhang Z, Song M, Liu X, Su Kang S, Duong DM, Seyfried NT, et al. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease. Nat Commun 2015
  6. [CrossRef] google scholar 6. Rodríguez-Martín T, Cuchillo-Ibáñez I, Noble W, Nyenya F, Anderton BH, Hanger DP. Tau phosphorylation affects its axonal transport and degradation. Neurobiol Aging 2013
  7. 34(9): 2146-57. [CrossRef] google scholar 7. Ashrafian H, Zadeh EH, Khan RH. Review on Alzheimer’s disease: Inhibition of amyloid beta and tau tangle formation. Int J Biol Macromol 2021
  8. [CrossRef] google scholar 8. Zhang Z, Song M, Liu X, Kang SS, Kwon IS, Duong DM, et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease. Nat Med 2014
  9. 20(11): 1254-62. [CrossRef] google scholar 9. Xiang J, Wang ZH, Ahn EH, Liu X, Yu SP, Manfredsson FP, et al. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer’s disease pathologies. Proc Natl Acad Sci U S A 2019
  10. 116(18): 9094-102. [CrossRef] google scholar 10. Chen SD, Wu CL, Hwang WC, Yang DI. More Insight into BDNF against neurodegeneration: Anti-apoptosis, anti-Oxidation, and suppression of autophagy. Int J Mol Sci 2017
  11. 18(3): 545 [CrossRef] google scholar 11. Miranda-Lourenço C, Ribeiro-Rodrigues L, Fonseca-Gomes J, Tanqueiro SR, Belo RF, Ferreira CB, et al. Challenges of BDNF-based therapies: From common to rare diseases. Pharmacol Res 2020
  12. 105281. [CrossRef] google scholar 12. Boyd JG, Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 2003
  13. 27(3): 277-324. [CrossRef] google scho